Sexual dysfunction in clinically stable patients with bipolar disorder receiving valproate

Area of Science:

• Psychiatry
• Pharmacology
• Sexual Medicine

Background:

• Bipolar disorder (BD) is a mood disorder often treated with mood stabilizers.
• Valproate is a commonly prescribed medication for bipolar disorder.
• Sexual dysfunction is a potential side effect of psychotropic medications.

Purpose of the Study:

• To determine the prevalence of sexual dysfunction in patients with bipolar disorder on valproate monotherapy.
• To identify factors associated with sexual dysfunction in this patient population.

Main Methods:

• Sixty-three clinically stable bipolar disorder patients on valproate monotherapy were assessed.
• Evaluations included the Arizona Sexual Experience Scale (ASEX) and the Udvalg for Kliniske Undersogelser (UKU) side effect subscale.
• Data on adherence and other clinical variables were also collected.

Main Results:

• Approximately 28.6% of patients experienced sexual dysfunction based on ASEX criteria.
• Sexual dysfunction manifested in various domains, including desire, arousal, and performance.
• Patients with sexual dysfunction had a longer duration of illness, higher rates of abnormal blood pressure, and greater UKU side effect scores.

Conclusions:

• A significant number of bipolar disorder patients on valproate monotherapy experience sexual dysfunction.
• Longer illness duration, abnormal blood pressure, and other side effects are associated with increased sexual dysfunction.
• Further research is needed to explore management strategies for valproate-induced sexual dysfunction.